ORAMED PHARMACEUTICALS INC. - Significant Ownership

Signature - Title
Oramed Pharmaceuticals Inc. - Avraham Gabay/Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ORAMED PHARMACEUTICALS INC..

Significant Ownership of ORAMED PHARMACEUTICALS INC.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCLX Scilex Holding Company Common Stock par value $0.0001 per share 6.2% $3.86M 15.5M Oramed Pharmaceuticals Inc. Jan 13, 2025

Schedules 13D/G Reported by ORAMED PHARMACEUTICALS INC.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.